
AstraZeneca/LinkedIn
Mar 22, 2025, 08:02
AstraZeneca announced plans to establish a new global strategic Research and Development center in Beijing
AstraZeneca shared a post LinkedIn:
“Today we announced plans to establish a new global strategic R/D centre in Beijing to advance our global efforts to bring innovative medicines to patients worldwide.
This investment reflects the rapid advancement of Beijing’s world-class life sciences ecosystem, the extensive opportunities for collaboration, access to talent, and our continued commitment to China.
Beijing will become our second strategic R/D centre in China, alongside Shanghai, and our sixth worldwide, with two centres in the US and two in Europe.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 22, 2025, 07:31
Mar 22, 2025, 07:12
Mar 22, 2025, 07:08